Showing results (41-50 of 97) with videos related to
Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerVanesa Gregorc, Samir Darwish, Vienna Ludovini, et al.Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerVanesa Gregorc, Vienna Ludovini, Lorenza Pistola, et al.ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.Critical Reviews in Oncology/Hematology|July 29, 2021
Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factorsFilippo Gagliardi, Pierfrancesco De Domenico, Silvia Snider, et al.Plos One|July 28, 2018
Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studiesFausto Petrelli, Chiara Lazzari, Raffaele Ardito, et al.BMC Research Notes|September 5, 2012
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experienceAlessandra Bearz, Renato Talamini, Gilda Rossoni, et al.Medicina (Kaunas, Lithuania)|January 23, 2024
Stenotrophomonas maltophilia Infections in Haematological Malignancies and Hematopoietic Stem Cell Transplantation: A Case Series including Cefiderocol-Based RegimensTommaso Lupia, Fabrizio Carnevale-Schianca, Davide Vita, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLCFederico Cappuzzo, Vanesa Gregorc, Elisa Rossi, et al.International Journal of Molecular Sciences|March 14, 2026
HER2 Alterations in Non-Small Cell Lung Cancer: Emerging Perspectives on the Therapeutic LandscapePaola Muscolino, Elena Fassi, Diego Signorelli, et al.Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancerVienna Ludovini, Vanesa Gregorc, Lorenza Pistola, et al.Pageof 10